Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease

Movement Disorders

Volumn 17, Issue 6, 2002, Pages 1305-1311

  Goudreau, John L ^a   Maraganore, Demetrius M ^a   Farrer, Matthew J ^b   Lesnick, Timothy G ^a   Singleton, Andrew B ^b   Bower, James H ^a   Hardy, John A ^b   Rocca, Walter A ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Case control study; COMT; DAT1; MAO B; Parkinson's disease; Polymorphisms; Susceptibility genes

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBIDOPA; CATECHOL METHYLTRANSFERASE; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; LEVODOPA; METHIONINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNOLOGY; FAMILY HISTORY; FEMALE; GENDER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TANDEM REPEAT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MIDWESTERN UNITED STATES; MINISATELLITE REPEATS; MONOAMINE OXIDASE; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0036869217     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10268     Document Type: Article

References (40)

1. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-980.
2. Uhl GR. Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease. Ann Neurol 1998;43:555-560.
3. Le Couteur DG, Leighton PW, McCann SJ, Pond SM. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Mov Disord 1997;12:760-763.
4. Higuchi S, Muramatsu T, Arai H, Hayashida M, Sasaki H, Trojanowski JQ. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. J Neural Transm 1995;10:107-113.
5. Mellick GD, Buchanan DD, McCann SJ, et al. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord 1999;14:219-224.
6. Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000;55:533-538.
7. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-372.
8. Kunugi H. Nanko S, Ueki A, et al. High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci Lett 1997;221:202-204.
9. Yoritaka A, Hattori N, Yoshino H, Mizuno Y. Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan. J Neural Transm 1997;104:1313-1317.
10. Maraganore DM, Farrer MJ, Hardy JA, Lincoln SJ, McDonnell SK, Rocca WA. Case-control study of the ubiquitin carboxyterminal hydrolase L1 gene in Parkinson's disease. Neurology 1999;53:1858-1860.
11. Maraganore DM, Fatter MJ, Hardy JA, McDonnell SK, Schaid DJ, Rocca WA. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease. Mov Disord 2000;15:714-719.
12. Maraganore DM, Hernandez DG, Singleton AB, et al. Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann Neurol 2001;50:658-661.
13. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
14. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord 2000; 15:819-825.
15. Sano A, Kondoh K, Kakimoto Y, Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 1993;91:405-406.
16. Hoda F, Nicholl D, Bennett P, et al. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochem Biophys Res Commun 1996;228:780-784.
17. Breslow NE. Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980.
18. Knowler WC, Williams RC, Pettitt DJ, Steinberg AG. Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet 1988;43:520-526.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. DSM-IV. Washington, DC: American Psychiatric Association; 1994.
20. Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992;14:1104-1106.
21. Heinz A, Goldman D, Jones DW, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000;22:133-139.
22. Mercier G, Turpin JC, Lucotte G. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found. J Neurol 1999;246:45-47.
23. Leighton PW, Le Couteur DG, Pang CCP, et al. The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology 1997;49:1577-1579.
24. Nicholl DJ, Bennett P, Hiller L, et al. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. Neurology 1999:53:1415-1421.
25. Planté-Bordeneuve V, Taussig D, Thomas F, et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 1997;48:1589-1593.
26. n repeat sequence in intron II of the human MAOB gene. Genomics 1992;12:176-177.
27. Riederer P, Konradi C, Hebenstreit G, Youdim MBH. Neurochemical perspectives to the function of monoamine oxidase. Acta Neurol Scand 1989;126:41-45.
28. Chiba K, Trevor A, Castagnoli N Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain mormamine oxidase. Biochem Biophys Res Common 1984;120:574-578.
29. Mellick GD, Buchanan DD, Silburn PA, et al. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population. J Neurol 2000;247:52-55.
30. Tanner CM, Ottman R, Goldman SM, et al. Parkinson's disease in twins. An etiological study. JAMA 1999;281:341-346.
31. Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm H-W, Malherbe P. Human catechol-O-methyltransferase: cloning and expression of the membrane associated form. Proc Natl Acad Sci U S A 1991;88:1416-1420.
32. Boudíková B, Szumlanski C, Maidak B, Weinshilboum R. Human liver catechol-O-methyltransferase phamacogenetics. Clin Pharmacol Ther 1990;48:381-389.
33. Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-4210.
34. 1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Mov Disord 1997;12:426-427.
35. Wu RM, Cheng CW, Chen KH. et al. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Neurology 2001;56:375-382.
36. Zhang H, Bonney G. Use of classification trees for association studies. Genet Epidemiol 2000;19:323-332.
37. Xie T, Ho S-L, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999;56:31-38.
38. Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51-63.
39. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York: Oxford University Press; 1993.
40. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-1238.